Neurodegeneration Enhances the Development of Arthritis

The prevalence of neurodegenerative disease and arthritis increases with age. Despite both processes being associated with immune activation and inflammation, little is known about the mechanistic interactions between neurodegenerative disease and arthritis. In this article, we show that tau-transgenic (tau-tg) mice that develop neurodegenerative disease characterized by deposition of tau tangles in the brain are highly susceptible to developing arthritis. Already at steady-state conditions, tau-tg mice exhibit peripheral immune activation that is manifested by higher numbers of granulocytes, plasmablasts, and inflammatory Ly6Chi CCR2+ monocytes, as well as increased levels of proinflammatory cytokines, such as TNF-α and IL-17. Upon induction of collagen-induced arthritis (CIA), tau-tg mice displayed an increased incidence and an earlier onset of CIA that was associated with a more pronounced inflammatory cytokine response. Furthermore, induction of CIA led to significantly elevated numbers of Iba-1–expressing cells in the brain, indicative of microglia activation, and the formation of anti-tau Abs in tau-tg mice. These changes were accompanied by the resolution of tau tangles and significantly decreased neurodegenerative pathology. In summary, these data show that neurodegenerative disease enhances the development of arthritis. In addition, arthritis, once induced, triggers innate immune responses in the brain, leading to resolution of neurodegenerative changes.

[1]  D. Holtzman,et al.  TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques , 2016, The Journal of experimental medicine.

[2]  E. Pamer,et al.  Innate Lymphocyte/Ly6Chi Monocyte Crosstalk Promotes Klebsiella Pneumoniae Clearance , 2016, Cell.

[3]  S. Pacini,et al.  Commentary: Structural and functional features of central nervous system lymphatic vessels , 2015, Front. Neurosci..

[4]  D. Wilkinson,et al.  Skeletal muscle homeostasis and plasticity in youth and ageing: impact of nutrition and exercise , 2015, Acta physiologica.

[5]  S. Paul,et al.  Microglial internalization and degradation of pathological tau is enhanced by an anti-tau monoclonal antibody , 2015, Scientific Reports.

[6]  Elizabeth A. Repasky,et al.  Fever and the thermal regulation of immunity: the immune system feels the heat , 2015, Nature Reviews Immunology.

[7]  R. Sankowski,et al.  Systemic Inflammation and the Brain: Novel Roles of Genetic, Molecular, and Environmental Cues as Drivers of Neurodegeneration , 2015, Front. Cell. Neurosci..

[8]  Ilia Stambler,et al.  The Critical Need to Promote Research of Aging and Aging-related Diseases to Improve Health and Longevity of the Elderly Population. , 2015, Aging and disease.

[9]  Keith A. Johnson,et al.  Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging , 2015, Neuropathology and applied neurobiology.

[10]  R. Papke,et al.  Two Novel α7 Nicotinic Acetylcholine Receptor Ligands: In Vitro Properties and Their Efficacy in Collagen-Induced Arthritis in Mice , 2015, PloS one.

[11]  Seng-Lai Tan,et al.  Combined Inhibition of Tumor Necrosis Factor α and Interleukin‐17 As a Therapeutic Opportunity in Rheumatoid Arthritis: Development and Characterization of a Novel Bispecific Antibody , 2015, Arthritis & rheumatology.

[12]  A. Barron,et al.  No Evidence of Pathogenic Involvement of Cathelicidins in Patient Cohorts and Mouse Models of Lupus and Arthritis , 2014, PloS one.

[13]  J. Pachter,et al.  Alterations in Tight Junction Protein and IgG Permeability Accompany Leukocyte Extravasation Across the Choroid Plexus During Neuroinflammation , 2014, Journal of neuropathology and experimental neurology.

[14]  S. Harper.  Economic and social implications of aging societies , 2014, Science.

[15]  T. Arumugam,et al.  Role of CCR2 in Inflammatory Conditions of the Central Nervous System , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  P. Acton,et al.  Systemic Immune Activation Leads to Neuroinflammation and Sickness Behavior in Mice , 2013, Mediators of inflammation.

[17]  Manuel Serrano,et al.  The Hallmarks of Aging , 2013, Cell.

[18]  Alcino J. Silva,et al.  mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies , 2013, Aging cell.

[19]  Andreas Hess,et al.  Association of brain functional magnetic resonance activity with response to tumor necrosis factor inhibition in rheumatoid arthritis. , 2013, Arthritis and rheumatism.

[20]  T. Mak,et al.  Lymphocyte-derived ACh regulates local innate but not adaptive immunity , 2013, Proceedings of the National Academy of Sciences.

[21]  York Winter,et al.  Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease–like pathology and cognitive decline , 2012, Nature Medicine.

[22]  Kevin J. Tracey,et al.  Neural reflexes in inflammation and immunity , 2012, The Journal of experimental medicine.

[23]  L. Buée,et al.  Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach. , 2012, Current Alzheimer research.

[24]  A. Bartoš,et al.  Increased Intrathecal High-Avidity Anti-Tau Antibodies in Patients with Multiple Sclerosis , 2011, PloS one.

[25]  E. Pamer,et al.  Monocyte recruitment during infection and inflammation , 2011, Nature Reviews Immunology.

[26]  J. Shin,et al.  Effects of collagen-induced rheumatoid arthritis on amyloidosis and microvascular pathology in APP/PS1 mice , 2011, BMC Neuroscience.

[27]  R. Ransohoff,et al.  Heterogeneity of CNS myeloid cells and their roles in neurodegeneration , 2011, Nature Neuroscience.

[28]  F. Rossi,et al.  Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool , 2011, Nature Neuroscience.

[29]  F. Berenbaum,et al.  Osteoarthritis: an update with relevance for clinical practice , 2011, The Lancet.

[30]  C. Howe,et al.  Isolation of brain-infiltrating leukocytes. , 2011, Journal of visualized experiments : JoVE.

[31]  A. Cardona,et al.  Isolation of brain and spinal cord mononuclear cells using percoll gradients. , 2011, Journal of visualized experiments : JoVE.

[32]  Ż. Smoleńska,et al.  Older age of rheumatoid arthritis onset is associated with higher activation status of peripheral blood CD4+ T cells and disease activity , 2011, Clinical and experimental immunology.

[33]  George Kollias,et al.  Blockade of TNF-α rapidly inhibits pain responses in the central nervous system , 2011, Proceedings of the National Academy of Sciences.

[34]  D. Quartermain,et al.  Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model , 2010, The Journal of Neuroscience.

[35]  C. Jorgensen,et al.  Myeloid cell subsets dynamic during progression of mouse collagen-induced arthritis , 2010, Journal of Translational Medicine.

[36]  P. Tak,et al.  Evaluation of therapeutic targets in animal models of arthritis: how does it relate to rheumatoid arthritis? , 2010, Arthritis and rheumatism.

[37]  M. Prinz,et al.  Tickets to the brain: Role of CCR2 and CX3CR1 in myeloid cell entry in the CNS , 2010, Journal of Neuroimmunology.

[38]  J. Shulman,et al.  Evidence for a common pathway linking neurodegenerative diseases , 2009, Nature Genetics.

[39]  E. Mandelkow,et al.  Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. , 2009, Human molecular genetics.

[40]  S. Rivest.  Regulation of innate immune responses in the brain , 2009, Nature Reviews Immunology.

[41]  R. Écochard,et al.  Genome-Wide Comparison between IL-17A- and IL-17F-Induced Effects in Human Rheumatoid Arthritis Synoviocytes1 , 2009, The Journal of Immunology.

[42]  M. Tansey,et al.  Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer’s disease , 2008, Journal of inflammation research.

[43]  T. Hohl,et al.  Monocyte-mediated defense against microbial pathogens. , 2008, Annual review of immunology.

[44]  R. Voll,et al.  Proteasome inhibition drastically but reversibly impairs murine lymphocyte development , 2008, Cell Death and Differentiation.

[45]  H. Zhang,et al.  Endothelial-Specific Knockdown of Interleukin-1 (IL-1) Type 1 Receptor Differentially Alters CNS Responses to IL-1 Depending on Its Route of Administration , 2007, The Journal of Neuroscience.

[46]  Georg Schett,et al.  Cytokines in the pathogenesis of rheumatoid arthritis , 2007, Nature Reviews Immunology.

[47]  Toshiki Uchihara,et al.  Silver diagnosis in neuropathology: principles, practice and revised interpretation , 2007, Acta Neuropathologica.

[48]  Bin Zhang,et al.  Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.

[49]  B. Melchior,et al.  CNS immune privilege: hiding in plain sight , 2006, Immunological reviews.

[50]  R. Peters,et al.  Ageing and the brain , 2006, Postgraduate Medical Journal.

[51]  F. LaFerla,et al.  Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.

[52]  Jing Chen,et al.  Exaggerated neuroinflammation and sickness behavior in aged mice after activation of the peripheral innate immune system , 2005 .

[53]  A. Kang,et al.  Immunopathogenesis of Collagen Arthritis , 2003, Springer Seminars in Immunopathology.

[54]  J. Gomori,et al.  Frontotemporal dementia and parkinsonism with the P301S tau gene mutation in a Jewish family , 2003, Journal of Neurology.

[55]  A. Silman,et al.  The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. , 2002, Rheumatology.

[56]  P. Miossec,et al.  Enhancing Effect of IL-1, IL-17, and TNF-α on Macrophage Inflammatory Protein-3α Production in Rheumatoid Arthritis: Regulation by Soluble Receptors and Th2 Cytokines1 , 2001, The Journal of Immunology.

[57]  R. Motter,et al.  Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease , 2000, Nature Medicine.

[58]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.

[59]  P. Miossec,et al.  Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines. , 2001, Journal of immunology.